Quantbot Technologies LP Biogen Inc. Transaction History

Quantbot Technologies LP

$2.36 Billion
Q3 2024

A detailed history of Quantbot Technologies LP transactions in Biogen Inc. stock. As of the latest transaction made, Quantbot Technologies LP holds 778 shares of BIIB stock, worth $115,937. This represents 0.01% of its overall portfolio holdings.

Number of Shares

778

Holding current value

$115,937

% of portfolio

0.01%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$189.07 - $236.8 $147,096 - $184,230	778 New	778 $150,000
Q1 2024 May 06, 2024	BUY	$212.02 - $267.71 $730,408 - $922,260	3,445 Added 519.61%	4,108 $885,000
Q4 2023 Feb 14, 2024	SELL	$222.59 - $267.94 $6,232 - $7,502	-28 Reduced 4.05%	663 $171,000
Q3 2023 Nov 07, 2023	BUY	$253.3 - $285.89 $175,030 - $197,549	691 New	691 $177,000
Q4 2022 Feb 13, 2023	SELL	$252.44 - $306.72 $586,418 - $712,510	-2,323 Reduced 71.92%	907 $251,000
Q3 2022 Nov 07, 2022	BUY	$194.69 - $268.46 $591,273 - $815,313	3,037 Added 1573.58%	3,230 $862,000
Q2 2022 Aug 09, 2022	SELL	$187.54 - $223.02 $945,951 - $1.12 Million	-5,044 Reduced 96.31%	193 $39,000
Q1 2022 May 16, 2022	BUY	$193.77 - $244.14 $995,396 - $1.25 Million	5,137 Added 5137.0%	5,237 $1.1 Million
Q4 2021 Feb 11, 2022	SELL	$223.92 - $287.77 $1.05 Million - $1.36 Million	-4,710 Reduced 97.92%	100 $23,000
Q3 2021 Nov 09, 2021	BUY	$282.99 - $369.05 $1.36 Million - $1.78 Million	4,810 New	4,810 $1.36 Million
Q1 2021 May 14, 2021	SELL	$242.95 - $284.63 $2.22 Million - $2.61 Million	-9,158 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$236.26 - $355.63 $2.16 Million - $3.26 Million	9,158 New	9,158 $2.24 Million
Q1 2020 May 13, 2020	SELL	$268.85 - $341.04 $1.61 Million - $2.05 Million	-6,003 Closed	0 $0
Q4 2019 Feb 10, 2020	SELL	$220.06 - $304.07 $1.45 Million - $2 Million	-6,572 Reduced 52.26%	6,003 $1.78 Million
Q3 2019 Nov 12, 2019	BUY	$217.44 - $243.88 $2.58 Million - $2.9 Million	11,875 Added 1696.43%	12,575 $2.93 Million
Q2 2019 Aug 13, 2019	BUY	$219.29 - $241.72 $153,503 - $169,204	700 New	700 $163,000
Q1 2019 May 13, 2019	SELL	$216.71 - $338.96 $628,892 - $983,661	-2,902 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$278.5 - $352.75 $808,207 - $1.02 Million	2,902 New	2,902 $873,000
Q3 2018 Nov 13, 2018	SELL	$293.51 - $383.83 $1.69 Million - $2.22 Million	-5,774 Closed	0 $0
Q2 2018 Aug 13, 2018	BUY	$257.52 - $306.91 $707,149 - $842,774	2,746 Added 90.69%	5,774 $1.68 Million
Q1 2018 May 11, 2018	BUY	$260.13 - $367.91 $703,911 - $995,564	2,706 Added 840.37%	3,028 $829,000
Q4 2017 Feb 12, 2018	SELL	$307.64 - $344.58 $1.1 Million - $1.24 Million	-3,587 Reduced 91.76%	322 $102,000
Q3 2017 Nov 07, 2017	BUY	$281.15 - $329.69 $1.1 Million - $1.29 Million	3,909	3,909 $1.22 Million

Others Institutions Holding BIIB

# of Institutions

1,037

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.5B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

News

Stay updated on Quantbot Technologies LP with notifications on news.

Account

Quantbot Technologies LP Biogen Inc. Transaction History